MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation

Molecular and Cellular Biochemistry
Yu YangLiang-Fang Shen

Abstract

MicroRNA (miRNA) dysregulation is causally related to cancer development and progression, and recent reports have revealed that DNA methylation constitutes an important mechanism for miRNA deregulation in cancer. MiR-129-2 has been reported to be down-regulated and functions as a tumor suppressor in a few human cancers. However, the involvement of miR-129-2 in the pathology of glioma and the mechanism underlying miR-129-2 regulation in glioma cells remain unclear. In this study, we performed quantitative PCR to investigate the level of miR-129-2 in 21 pairs of glioma tumors and matched adjacent tissues and found that miR-129-2 is down-regulated in glioma tumors. In vitro cell growth, apoptosis, cell migration, and invasion assays revealed that miR-129-2 functions as a tumor suppressor in glioma cells. Luciferase reporter assay found that miR-129-2 could directly target high-mobility group box 1 (HMGB1) and inhibit its expression in glioma cells. Methylation-specific PCR found that DNA methylation in upstream regions of miR-129-2 occured more frequently in cancer tissues than in adjacent tissues. Demethylation of miR-129-2 by 5-aza-2'-deoxycytidine treatment and quantitative PCR analysis revealed that miR-129-2 expression is epi...Continue Reading

References

Sep 17, 2003·Journal of Internal Medicine·C J TreutigerJ E W Palmblad
Oct 18, 2003·Seminars in Cancer Biology·Michael T McManus
Feb 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
May 28, 2004·Nature·Gerda EggerPeter A Jones
Sep 17, 2004·Nature·Victor Ambros
Jul 2, 2005·Molecular Cell·Christian Schwerk, Klaus Schulze-Osthoff
Sep 23, 2006·Developmental Biology·Baohong ZhangTodd A Anderson
May 18, 2007·Annual Review of Cell and Developmental Biology·Natascha Bushati, Stephen M Cohen
Nov 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marilena V Iorio, Carlo M Croce
Feb 4, 2010·Biochimica Et Biophysica Acta·Daolin TangMichael T Lotze
Mar 25, 2010·Biochemical and Biophysical Research Communications·Ruizhe ShenShidan Cheng
Aug 5, 2010·Cancer Research·Francesc BalaguerAjay Goel
Oct 1, 2011·International Journal of Cancer. Journal International Du Cancer·Kuo-Wang TsaiWen-Chang Lin
Feb 1, 2013·International Journal of Cancer. Journal International Du Cancer·Sumadi Lukman AnwarUlrich Lehmann
Feb 14, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Xiangmei ChenFengmin Lu
Dec 19, 2013·Frontiers in Genetics·Hiromu SuzukiMasahiro Kai
Jul 11, 2014·Medical Oncology·Danping WangJunming Guo
Jul 11, 2014·Molecular Aspects of Medicine·Rui KangDaolin Tang
Jan 7, 2015·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Jing ZhangRuiguang Hou

❮ Previous
Next ❯

Citations

Jun 6, 2016·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Efthalia AngelopoulouAthanasios G Papavassiliou
Jun 12, 2016·Briefings in Functional Genomics·Veronique G LeBlanc, Marco A Marra
Apr 22, 2017·Journal of Neuropathology and Experimental Neurology·Heather AmesFausto J Rodriguez
Feb 13, 2018·Journal of Cellular and Molecular Medicine·Yuling DiaoWenke Zhou
May 29, 2018·Journal of Cellular and Molecular Medicine·Zhiyong XiongYe Yuan
Jan 18, 2018·Archives of Gynecology and Obstetrics·Miłosz WilczyńskiJacek R Wilczyński
Feb 12, 2019·Journal of Cellular Physiology·Behzad MansooriBehzad Baradaran
Jun 18, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Keqian ZhangZhe Wang
Apr 14, 2018·BioMed Research International·Jianing YanXiujun Cai
Aug 6, 2019·Frontiers in Immunology·Carolina M GorgulhoMichael T Lotze
Aug 12, 2016·International Journal of Molecular Medicine·Qifang LiuWu Wei
Jun 16, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Guodong TangQing Liu
Apr 19, 2018·Frontiers in Immunology·Brianne CruickshankShashi Gujar
Sep 12, 2018·Hepatology Communications·Harriet GaskellNatalia Nieto
Jan 19, 2020·Molecular Therapy. Nucleic Acids·Atieh MoradimotlaghMasoud Soleimani

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
transfection

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis